Molecular insight of drug design / / edited by Arli Aditya Parikesit.
The approaches in drug design are mainly comprised of these three multidisciplinary sciences. First, Bioinformatics has successfully gather biological data in form of biomolecular sequences, in order to construct knowledge on drug and vaccine design. It is of considerable importance for drug designe...
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | London, England : : IntechOpen,, [2018] ©2018 |
Year of Publication: | 2018 |
Language: | English |
Physical Description: | 1 online resource (x, 119 pages) :; illustrations |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545910804498 |
---|---|
ctrlnum |
(CKB)4970000000100124 (NjHacI)994970000000100124 (oapen)https://directory.doabooks.org/handle/20.500.12854/53841 (EXLCZ)994970000000100124 |
collection |
bib_alma |
record_format |
marc |
spelling |
Arli Aditya auth Molecular insight of drug design / edited by Arli Aditya Parikesit. IntechOpen 2018 London, England : IntechOpen, [2018] ©2018 1 online resource (x, 119 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on: online resource; title from PDF information screen (InTech, viewed October 12, 2022). The approaches in drug design are mainly comprised of these three multidisciplinary sciences. First, Bioinformatics has successfully gather biological data in form of biomolecular sequences, in order to construct knowledge on drug and vaccine design. It is of considerable importance for drug designers to comprehend the utilization of bioinformatics tools for resolving their research questions. Second, Nanotechnology has made possible the design and delivery of the nano-based drug. Third, Pharmaceutical Chemistry made it possible to investigate the adsorption, distribution, metabolism, and toxicology of the drug candidates in a fine-grained resolution. English Bioinformatics. Computational biology. Drugs Design. Toxicology and Pharmaceutical Science Pharmacology Drug Discovery Health Sciences 1-78923-632-0 Parikesit, Arli Aditya, editor. |
language |
English |
format |
eBook |
author |
Arli Aditya |
spellingShingle |
Arli Aditya Molecular insight of drug design / |
author_facet |
Arli Aditya Parikesit, Arli Aditya, |
author_variant |
a a aa |
author2 |
Parikesit, Arli Aditya, |
author2_variant |
a a p aa aap |
author2_role |
TeilnehmendeR |
author_sort |
Arli Aditya |
title |
Molecular insight of drug design / |
title_full |
Molecular insight of drug design / edited by Arli Aditya Parikesit. |
title_fullStr |
Molecular insight of drug design / edited by Arli Aditya Parikesit. |
title_full_unstemmed |
Molecular insight of drug design / edited by Arli Aditya Parikesit. |
title_auth |
Molecular insight of drug design / |
title_new |
Molecular insight of drug design / |
title_sort |
molecular insight of drug design / |
publisher |
IntechOpen IntechOpen, |
publishDate |
2018 |
physical |
1 online resource (x, 119 pages) : illustrations |
isbn |
1-83881-609-7 1-78923-633-9 1-78923-632-0 |
callnumber-first |
Q - Science |
callnumber-subject |
QH - Natural History and Biology |
callnumber-label |
QH324 |
callnumber-sort |
QH 3324.2 M654 42018 |
illustrated |
Illustrated |
dewey-hundreds |
500 - Science |
dewey-tens |
570 - Life sciences; biology |
dewey-ones |
570 - Life sciences; biology |
dewey-full |
570.285 |
dewey-sort |
3570.285 |
dewey-raw |
570.285 |
dewey-search |
570.285 |
work_keys_str_mv |
AT arliaditya molecularinsightofdrugdesign AT parikesitarliaditya molecularinsightofdrugdesign |
status_str |
n |
ids_txt_mv |
(CKB)4970000000100124 (NjHacI)994970000000100124 (oapen)https://directory.doabooks.org/handle/20.500.12854/53841 (EXLCZ)994970000000100124 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Molecular insight of drug design / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1787551971907993600 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01077nam a2200325 i 4500</leader><controlfield tag="001">993545910804498</controlfield><controlfield tag="005">20221012195505.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221012s2018 enka o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-83881-609-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-78923-633-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4970000000100124</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994970000000100124</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/53841</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994970000000100124</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QH324.2</subfield><subfield code="b">.M654 2018</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570.285</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Arli Aditya</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Molecular insight of drug design /</subfield><subfield code="c">edited by Arli Aditya Parikesit.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2018</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, England :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">[2018]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (x, 119 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 12, 2022).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The approaches in drug design are mainly comprised of these three multidisciplinary sciences. First, Bioinformatics has successfully gather biological data in form of biomolecular sequences, in order to construct knowledge on drug and vaccine design. It is of considerable importance for drug designers to comprehend the utilization of bioinformatics tools for resolving their research questions. Second, Nanotechnology has made possible the design and delivery of the nano-based drug. Third, Pharmaceutical Chemistry made it possible to investigate the adsorption, distribution, metabolism, and toxicology of the drug candidates in a fine-grained resolution.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Bioinformatics.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Computational biology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Design.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Toxicology and Pharmaceutical Science</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmacology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Drug Discovery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health Sciences</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-78923-632-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Parikesit, Arli Aditya,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 20:07:38 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-04-13 22:04:18 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5351654810004498&Force_direct=true</subfield><subfield code="Z">5351654810004498</subfield><subfield code="b">Available</subfield><subfield code="8">5351654810004498</subfield></datafield></record></collection> |